Jaguar Animal Health (JAGX)
(Delayed Data from NSDQ)
$0.29 USD
-0.02 (-5.62%)
Updated May 10, 2024 04:00 PM ET
After-Market: $0.30 +0.01 (2.70%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth B Momentum C VGM
Price, Consensus and EPS Surprise
JAGX 0.29 -0.02(-5.62%)
Will JAGX be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for JAGX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for JAGX
Jaguar Animal Health, Inc. (JAGX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
JAGX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for JAGX
Jaguar Health announces submission of clinical trial applications for crofelemer
Jaguar Health Announces Submission of Clinical Trial Applications for Crofelemer for the Rare Disease Indications Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome (SBS) in Europe
Peering Into Jaguar Health's Recent Short Interest
Jaguar Health to Hold Investor Webcast Tuesday, May 14th at 8:30 AM Eastern Regarding Q1 2024 Financials & Corporate Updates
Want $10,000? Invest $1,000 in These 3 Penny Stocks Now